Curated News
By: NewsRamp Editorial Staff
July 14, 2026
NuggMD Donates to NORML After Federal Cannabis Rescheduling
TLDR
- NuggMD gains competitive edge by donating 3% of revenue to NORML, aligning with cannabis law changes and expanding patient access.
- Federal rescheduling of cannabis to Schedule 3 allows doctor-recommended use; NuggMD facilitates evaluations via telehealth in multiple countries.
- Federal recognition of cannabis' medical use improves patient care and access, with NuggMD supporting advocacy for fair consumer treatment.
- NORML and NuggMD highlight that political gains in cannabis reform require continued advocacy from patients and consumers.
Impact - Why it Matters
This news matters because it highlights a pivotal shift in federal cannabis policy, recognizing medical use for the first time. For patients and consumers, it means safer access and reduced legal risks. However, the ongoing hearing for non-medical cannabis shows the fight isn't over. NuggMD's donation supports NORML's advocacy, which is crucial for protecting gains and pushing for broader legalization. Readers should care because these developments affect millions who use cannabis legally and signal potential future reforms.
Summary
In a historic move this April, the federal government reclassified cannabis to a less-restrictive category, marking the first official acknowledgment of its medical use. This shift has allowed millions of Americans to access federally legal, Schedule 3 cannabis under a doctor's recommendation, effectively ending federal prohibition for these patients. However, a separate hearing this week will determine the fate of non-medical cannabis, highlighting the ongoing battle between advocates and prohibitionists. Despite this, the medical channel remains secure, a testament to the progress made by advocacy groups like NORML.
To celebrate this milestone, NuggMD, a leading cannabis telehealth platform, has pledged to donate 3% of its revenue this week to NORML. NuggMD CEO Charlie Russell expressed excitement about supporting NORML's critical work in defending patient rights and consumer access. NORML deputy director Paul Armentano emphasized that advocacy remains essential even after legislative victories, as political gains can be lost without continued effort. He called on patients and consumers to keep leading the charge, noting that their voices are the most powerful tools for change.
NuggMD has facilitated over 2.5 million medical cannabis evaluations since 2015, operating in most U.S. states, the UK, and Germany. This donation underscores the company's commitment to advancing cannabis access and consumer rights. The news marks a significant step forward, but the fight for full legalization and fair treatment of all cannabis users continues.
Source Statement
This curated news summary relied on content disributed by Newsworthy.ai. Read the original source here, NuggMD Donates to NORML After Federal Cannabis Rescheduling
